.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Eric Lev
Eric LevAMPERSAND CAPITAL PARTNERS

Eric Lev

Partner at AMPERSAND CAPITAL PARTNERS

Investor

Deal Bio

Total Deals6
Valued Deals1
Total Value£184M
Avg. Deal Size£184M

Expertise (6)

Key Relationships

United States
Pharmaceuticals
Private EquityAcquisitionMajorityMergerPrivate
Peptides International

target

Peptides International

Ampersand Capital Partners

bidder

Ampersand Capital Partners

value n/a

4 dealmakers

United States
Biotechnology
AcquisitionMajorityDomesticPrivatePrivate Equity
Nexcelom Bioscience

target

Nexcelom Bioscience

Perkinelmer

bidder

Perkinelmer

£183m

7 dealmakers

Canada
Pharmaceuticals
MajorityPrivatePrivate EquityCross BorderAcquisition
NEXELIS

target

NEXELIS

Iqvia

bidder

Iqvia

value n/a

28 dealmakers

United Kingdom
Pharmaceuticals
Cross BorderMajorityPrivateAcquisitionPrivate Equity
Lgc (drug Development Solutions Business)

target

Lgc (drug Development Solutions Business)

Alliance Pharma Lc

bidder

Alliance Pharma Lc

value n/a

27 dealmakers

Czechia
Medical Equipment
AcquisitionCross BorderMergerPrivate EquityPrivate
GENEPROOF

target

GENEPROOF

American Laboratory Products Company

bidder

American Laboratory Products Company

value n/a

13 dealmakers

United States
Biotechnology
DomesticPrivate EquityMajorityPrivateAcquisition
Biologos

target

Biologos

Ampersand Capital Partners

bidder

Ampersand Capital Partners

value n/a

4 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US